Helping Aussie kids reach their full potential

The human brain undergoes massive developmental change from infancy to early adulthood. Disruption to neurodevelopment can be dramatic, leading to clinical conditions marked by failure to attain appropriate cognitive, motor, emotional or social developmental milestones.

The human brain undergoes massive developmental change from infancy to early adulthood. Disruption to neurodevelopment can be dramatic, leading to clinical conditions marked by failure to attain appropriate cognitive, motor, emotional or social developmental milestones.

MICCN is making a real difference to the understanding of neurodevelopment and treatment of children with neurodevelomental disorders, such as those with Autism and ADHD, enabling thousands of Australian children to reach their full potential. Ideas and innovation from MICCN’s leading researchers - including Professor Peter Anderson whose work we highlight here - are behind several world leading products and services that are changing children’s lives for the better.

“Integrating knowledge from genetics, pharmacology and behavioural, cognitive and developmental neuroscience with that of clinical psychology and psychiatry enriches our understanding of developmental processes,” MICCN’s Professor Peter Anderson said. “We are supported by cutting edge technologies such as electroencephalography (EEG), oculomotor neurophysiology, transcranial magnetic stimulation (TMS) and structural and functional brain imaging to link brain and behaviour. Our strong neuroscience focus combined with our rich clinical research ensures that our discoveries are relevant and translatable, for example, to our resulting interventions, while also being grounded in the mechanisms of the disorders that we study.”

Professor Anderson’s work focuses on understanding the brain and cognitive development following early brain insults. For the past 15 years, his program has centred on neonatal conditions, especially infants born very preterm.  As a senior member of the MICCN Attention and Memory Program, and an NHMRC Senior Research Fellow, Professor Anderson is expanding and enhancing MICCN’s research into neurodevelopment disorders, including by fostering collaborations with several key partners such as the new Monash Children’s Hospital.

Professor Anderson aims to establish an industry partnership to transform an existing evidenced-based early intervention program for sick infants into a telehealth platform. The telehealth platform will reduce costs and allow access to the sick infants program to rural and regional children and their families. “MICCN works best when it works together with industry – combining methods, ideas and knowledge for greater strength,” Professor Anderson said. “Our own research strengths are enhanced through these partnerships, but these collaborations also allow industry partners to access to our leading researchers and cutting-edge research infrastructure, to make a real difference to the lives of Australian children and their families.”

To get involved and for more information on industry collaboration opportunities, contact Dr Jodie Palmer on t: 03 9902 0835, e: Jodie.Palmer@monash.edu.

For more information on Professor Anderson’s research, contact him on t: 03 9903 2251, 
e: Peter.J.Anderson@monash.edu.

Follow MICCN: Twitter and Facebook